These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28502636)

  • 1. Diabetogenic agent alloxan is a proteasome inhibitor.
    Zhou W; Wei L; Xiao T; Lai C; Peng M; Xu L; Luo X; Deng S; Zhang F
    Biochem Biophys Res Commun; 2017 Jun; 488(2):400-406. PubMed ID: 28502636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilirubin neurotoxicity is associated with proteasome inhibition.
    Huang H; Guo M; Liu N; Zhao C; Chen H; Wang X; Liao S; Zhou P; Liao Y; Chen X; Lan X; Chen J; Xu D; Li X; Shi X; Yu L; Nie Y; Wang X; Zhang CE; Liu J
    Cell Death Dis; 2017 Jun; 8(6):e2877. PubMed ID: 28617443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death.
    Sanchez G; Berrios D; Olmedo I; Pezoa J; Riquelme JA; Montecinos L; Pedrozo Z; Donoso P
    PLoS One; 2016; 11(8):e0161068. PubMed ID: 27529620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity.
    Neilsen PM; Pehere AD; Pishas KI; Callen DF; Abell AD
    ACS Chem Biol; 2013 Feb; 8(2):353-9. PubMed ID: 23190346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ridaifen-F conjugated with cell-penetrating peptides inhibits intracellular proteasome activities and induces drug-resistant cell death.
    Tanaka M; Zhu Y; Shionyu M; Ota N; Shibata N; Watanabe C; Mizusawa A; Sasaki R; Mizukami T; Shiina I; Hasegawa M
    Eur J Med Chem; 2018 Feb; 146():636-650. PubMed ID: 29407987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of human immuno- and constitutive proteasomes inhibitors.
    Richy N; Sarraf D; Maréchal X; Janmamode N; Le Guével R; Genin E; Reboud-Ravaux M; Vidal J
    Eur J Med Chem; 2018 Feb; 145():570-587. PubMed ID: 29339252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of peptidomimetic boronates as proteasome inhibitors.
    Micale N; Ettari R; Lavecchia A; Di Giovanni C; Scarbaci K; Troiano V; Grasso S; Novellino E; Schirmeister T; Zappalà M
    Eur J Med Chem; 2013 Jun; 64():23-34. PubMed ID: 23639651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tamoxifen derivative, ridaifen-F, is a nonpeptidic small-molecule proteasome inhibitor.
    Hasegawa M; Yasuda Y; Tanaka M; Nakata K; Umeda E; Wang Y; Watanabe C; Uetake S; Kunoh T; Shionyu M; Sasaki R; Shiina I; Mizukami T
    Eur J Med Chem; 2014 Jan; 71():290-305. PubMed ID: 24321833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ferulic Acid, a Phenolic Inducer of Fungal Laccase, on 26S Proteasome Activities In Vitro.
    Swatek A; Staszczak M
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32252291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.
    Scotti A; Trapella C; Ferretti V; Gallerani E; Gavioli R; Marastoni M
    J Enzyme Inhib Med Chem; 2016; 31(3):456-63. PubMed ID: 25942361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of quercetin on the activity of purified 20S, 26S proteasome and proteasomal activity in isolated cardiomyocytes].
    Dosenko VE; Nagibin VS; Tumanovskaia LV; Zagoriĭ VIu; Moĭbenko AA
    Biomed Khim; 2006; 52(2):138-45. PubMed ID: 16805384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening.
    Di Giovanni C; Ettari R; Sarno S; Rotondo A; Bitto A; Squadrito F; Altavilla D; Schirmeister T; Novellino E; Grasso S; Zappalà M; Lavecchia A
    Eur J Med Chem; 2016 Oct; 121():578-591. PubMed ID: 27318981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of N-3-methyladenine on peptidase and ribonuclease activity of proteasome].
    Dosenko VE; Zagoriĭ VIu; Nagibin VS; Moĭbenko AA
    Ukr Biokhim Zh (1999); 2005; 77(5):52-6. PubMed ID: 16846070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncovalent inhibitors of human 20S and 26S proteasome based on trypsin inhibitor SFTI-1.
    Dębowski D; Cichorek M; Lubos M; Wójcik S; Łęgowska A; Rolka K
    Biopolymers; 2016 Sep; 106(5):685-96. PubMed ID: 27258473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2,4-Oxadiazoles identified by virtual screening and their non-covalent inhibition of the human 20S proteasome.
    Maréchal X; Genin E; Qin L; Sperandio O; Montes M; Basse N; Richy N; Miteva MA; Reboud-Ravaux M; Vidal J; Villoutreix BO
    Curr Med Chem; 2013; 20(18):2351-62. PubMed ID: 23531222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells.
    Kapadia MR; Eng JW; Jiang Q; Stoyanovsky DA; Kibbe MR
    Nitric Oxide; 2009 Jun; 20(4):279-88. PubMed ID: 19233305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides.
    Artschwager R; Ward DJ; Gannon S; Brouwer AJ; van de Langemheen H; Kowalski H; Liskamp RMJ
    J Med Chem; 2018 Jun; 61(12):5395-5411. PubMed ID: 29782167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine.
    Jorda R; Dušek J; Řezníčková E; Pauk K; Magar PP; Imramovský A; Kryštof V
    Eur J Med Chem; 2017 Jul; 135():142-158. PubMed ID: 28441582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.
    Villoutreix BO; Khatib AM; Cheng Y; Miteva MA; Maréchal X; Vidal J; Reboud-Ravaux M
    Oncotarget; 2017 Feb; 8(6):10437-10449. PubMed ID: 28060729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
    Ge Y; Li A; Wu J; Feng H; Wang L; Liu H; Xu Y; Xu Q; Zhao L; Li Y
    Eur J Med Chem; 2017 Mar; 128():180-191. PubMed ID: 28182990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.